![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, December 14, 2003 4:14:19 PM
That's why I'm invested here. I believe that DNAP is at a stage where public exposure will really start to accelerate and compliment the science, which together should bring greater interest to this little company down south. And with that interest, I believe that many investors should come to realize how undervalued we are at $26M...
This exposure could be from various issues: continued AncestryByDNA awareness, growing DNAWitness use and related press, possible OVANOME classifier being filed with FDA, adding RETINOME to DNAWitness, improved AncestryByDNA versions 2.5 and 3.0, patent related PR's, additional journal and magazine articles like the one due out in December and the one published last month in Popular Science, possible lab accreditation, possible announcement of a large customer/investor for drug discovery, additonal financing, etc, etc.
And mix in the revenue growth that we're finally seeing and DNAP is clearly taking the form of a "real" company with revenues that the average investor can associate with. Many people need to see revenue (& growth) to justify their investment. Don't forget the fact that this revenue growth will be coming from areas that will only support the larger (humongous) growth opportunities that Tony and we get real excited about!! Ovarian cancer, statins, transplants, breast cancer, and many, many other opportunities we haven't heard of yet. Not to mention their drug discovery platform and related software.
Now with funding, the extra manpower and future 2nd lab will really decrease the time to market (and time to patent application!) for additional opportunities.
Personnaly, I like the DNAP storyline, love the science and think $0.05 is a bargain given the expected exposure they should start getting.
One area that I'd appreciate some additional input on is the agreement with ORCH. Can someone explain this to me? Thanks.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM